Haemophilia B Leyden arising de novo by point mutation in the putative factor IX promoter region
- 1 February 1991
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 77 (2) , 191-194
- https://doi.org/10.1111/j.1365-2141.1991.tb07976.x
Abstract
Haemophilia B Leyden is characterized by severe factor IX deficiency during childhood with partial resolution at puberty or following the administration of anabolic steroids. The disorder has recently been associated with point mutations in the putative factor IX promoter region, which contains an imperfect direct repeat spanning a possible start site of transcription. We have identified a T to C transition at position +8 in the promoter region of a patient with the haemophilia B Leyden phenotype. A mutation at this site has not been previously reported and occurs within the repeat consensus sequence in the transcribed but untranslated portion of the gene. There is no family history of haemophilia and sequence analysis of his mother and other family members indicates that the mutation has arisen de novo in this patient. This observation provides further support for a causal relationship between point mutations in the presumptive promoter region of the factor IX gene and the Leyden phenotype.Keywords
This publication has 15 references indexed in Scilit:
- Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia BNature, 1990
- Direct sequencing from low-melt agarose with Sequenase@Nucleic Acids Research, 1989
- A simple method for DNA purification from peripheral bloodAnalytical Biochemistry, 1988
- An Improved Method for Prenatal Diagnosis of Genetic Diseases by Analysis of Amplified DNA SequencesNew England Journal of Medicine, 1987
- Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell AnemiaScience, 1985
- The Prophylactic Treatment of Hemophilia B Leyden with Anabolic SteroidsAnnals of Internal Medicine, 1985
- Complete nucleotide sequences of the gene for human factor IX (antihemophilic factor B)Biochemistry, 1985
- Isolation and characterization of a cDNA coding for human factor IX.Proceedings of the National Academy of Sciences, 1982
- Molecular cloning of the gene for human anti-haemophilic factor IXNature, 1982
- Hemophilia B LeydenNew England Journal of Medicine, 1982